Status:
UNKNOWN
Chinese Herb for the Treatment of Depression and Anxiety Disorders
Lead Sponsor:
Mazra Mental Health Center
Collaborating Sponsors:
The Academic College of Tel-Aviv Yaffo
Conditions:
Depression, Anxiety
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
Anxiety and depression are currently among the ten most important public health concerns, and in recent years, have reached epidemic proportions. Anxiety is recognized as the main risk factor for many...
Detailed Description
The relationship between depression and anxiety disorders has long been described, and comorbid depression and anxiety are highly prevalent conditions. The current study will focus on mild to moderate...
Eligibility Criteria
Inclusion
- Patients of both sexes suffering from mild to moderate depressive episode of major depressive disorder (MDD) according to Diagnostic and Statistical Manual Diploma in Social Medicine (DSM)-V.
- Subjects of both sexes meeting the DSM-V criteria for dysthymia.
- Patients of both sexes meeting the DSM-V criteria for Generalized Anxiety Disorder (GAD), Panic Disorder and Social Anxiety Disorder, Adjustment disorder.
- Age 18-65.
- Not receiving antidepressant drugs.
- Hamilton Depression Rating Scale (HAM-D) scores are ≥8 and ≤ 18.
- Hamilton Anxiety Rating Scale (HAM-A) scores ≥17 and ≤ 30.
Exclusion
- Current active and persistent substance and/or alcohol abuse.
- Mental retardation
- Other major psychiatric disorders: Psychosis, Severe MDD and Bipolar disorder
- Suicide ideation
- Pregnancy
- Systolic Blood Pressure \< 100 mm Hg
- Heart rate \< 60 times/min
- Patient with medical history of cardiac palpitation and other cardiac diseases
Key Trial Info
Start Date :
August 28 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2018
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03323697
Start Date
August 28 2017
End Date
December 30 2018
Last Update
October 27 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mazor MHC
Acre, Israel, 25201